Patent Yard Sign in
Canadian application, no grantCanada

Norbornene derivative and norbornene polymer obtained therefrom through ring-opening polymerization

CA 2459384 A1 · Owner: Miyaki, Nobuyuki · Inventors: Fukuhara, Seiji; Ootsuki, Toshihiro; Miyaki, Nobuyuki

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A novel norbornene derivative represented by the following general formula (1m). The norbornene derivative is subjected to ring-opening polymerization or subjected to ring-opening polymerization and subsequently to hydrogenation. Thus, a ring-opening polymerization polymer or a product of hydrogenation thereof can be obtained which can especially have significantly reduced birefringence. (1m) In the formula, at least one of R1 to R4 is a group selected between an aromatic-ring-containing group represented by the following general formula (1-1) and an aromatic-ring-containing group represented by the general formula (1-2): wherein one of RA RB, and Z is a , group represented by the …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 8, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 8, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 8, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 8, 2002
GrantedNo grant recorded
Term endedOctober 8, 2022
Patent numberCA 2459384 A1
Classification (IPC)C07C69/76 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedOct 8, 2002Term endedOct 8, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.